The increase in price target by a reputable analyst firm like Jefferies suggests a positive sentiment towards Regeneron Pharmaceuticals. This could lead to increased investor confidence and a potential short-term rise in the stock price, as market participants may view the new price target as a sign of continued growth or undervaluation.